Demo Sign up Log In

West Pharmaceutical Services (WST)

EBITDA Margin

26.17%

TTM · Period ending: Jun 30, 2026

WST EBITDA Margin

Latest reported26.17%period endingJun 30, 2026

Latest reported26.17%period endingJun 30, 2026

WST EBITDA Margin (18.67% → 26.17%)

Annual ebitda margin

High-resolution chart · PNG

WST ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services EBITDA Margin — Annual fiscal periods
Period ending	EBITDA Margin
Dec 31, 2025	25.0708%
Dec 31, 2024	25.713%
Dec 31, 2023	28.6029%
Dec 31, 2022	28.0055%
Dec 31, 2021	31.0771%
Dec 31, 2020	24.172%
Dec 31, 2019	21.8703%
Dec 31, 2018	20.5588%
Dec 31, 2017	20.385%
Dec 31, 2016	19.0113%
Dec 31, 2015	15.5722%
Dec 31, 2014	19.5892%
Dec 31, 2013	18.433%
Dec 31, 2012	15.7928%
Dec 31, 2011	15.3782%
Dec 31, 2010	14.6012%
Dec 31, 2009	15.7621%
Dec 31, 2008	17.7053%
Dec 31, 2007	15.4397%
Dec 31, 2006	16.413%
Dec 31, 2005	17.5647%
Dec 31, 2004	17.4483%
Dec 31, 2003	17.2814%
Dec 31, 2002	19.7284%
Dec 31, 2001	18.8209%
Dec 31, 2000	17.6471%
Dec 31, 1999	21.7651%
Dec 31, 1998	21.5699%
Dec 31, 1997	20.7293%
Dec 31, 1996	18.3086%
Dec 31, 1995	18.8666%
Dec 31, 1994	19.2276%
Dec 31, 1993	18.0958%
Dec 31, 1992	18.7167%
Dec 31, 1991	7.0388%
Dec 31, 1990	13.5829%
Dec 31, 1989	18.2702%
Dec 31, 1988	17.1062%
Dec 31, 1987	18.4366%
Dec 31, 1986	19.3124%
Dec 31, 1985	18.6744%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.